Honda S, Farboud B, Hjelmeland LM, Handa JT
5.1 GLP-1R agonists Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide and liraglutide, offer comprehensive metabolic benefits in patients with CRHM syndrome
Enhanced Muscle Growth and Repair Certain peptides, such as growth hormone-releasing peptides (GHRPs) and insulin-like growth factor 1 (IGF-1), can stimulate the production of growth hormone and promote muscle growth and repair
Its the primary research signal
Peptide therapy restores the number of peptides to stimulate cellular growth, which leads to repair of body systems, brain health, gut restoration, promotes anti-aging, helps with inflammation reduction and weight loss
Most users implement the stack after establishing tolerance to Retatrutide alone, typically after reaching stable maintenance doses around weeks 12 to 16 of triple agonist therapy